Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Sturge-Weber Syndrome

Below is an extended Sturge-Weber Syndrome patents listing. Click here to return to the Sturge-Weber Syndrome main in depth entry.

Patents :

US Patent No.Title
7357927 Death domain containing receptors
7425622 Antibodies against C3a receptor
7429646 Antibodies to human tumor necrosis factor receptor-like 2
7432303 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
7435808 Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2
7446176 12 human secreted proteins
7452538 Death domain containing receptor 4 antibodies and methods
7456256 BGS 4
7459531 50 Human secreted proteins
7459532 Variants of the TRP channel family member, LTRPC3G
7465707 Methods of treatment with TR10 polypeptides
7411051 Antibodies to HDPPA04 polypeptide
7404969 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7402312 Antibodies to vascular endothelial growth factor 2 (VEGF-2)
7358074 Human phosphatase RET31, and variants thereof
7359748 Apparatus for total immersion photography
7361341 Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
7368527 HADDE71 polypeptides
7368531 Human secreted proteins
7371388 Treatment of Sjogren's syndrome by administration of TR18 polypeptides
7371822 Human G-protein coupled receptor variant of HM74, HGPRBMY74
7381800 Antibodies to HBIMF63 polypeptide
7390637 Keratinocyte derived interferon
7393934 Human G-protein chemokine receptor (CCR5) HDGNR10
7476384 Death domain containing receptor 4 antibody and methods
7482013 Albumin fusion proteins
7531310 Methods of diagnosing Crohn's disease by measuring expression level of RNA encoding human G-protein coupled receptor, HGPRBMY11
7534428 Antibodies to tumor necrosis factor receptors 6.alpha. and 6.beta.
7547687 Therapeutic treatment methods
7550569 Antibodies that specifically bind to GMAD
7569384 Albumin fusion proteins
7572618 Polynucleotides encoding novel PCSK9 variants
7592010 Albumin fusion proteins
7592325 Methods and compositions for the treatment of eye disorders with increased intraocular pressure
7595038 Methods of treatment using antibodies to follistatin-3
7597886 Tumor necrosis factor-gamma
7524816 Peptides and supported peptides for treating skin diseases
7521424 Albumin fusion proteins
7517864 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
7482334 Therapeutic treatment methods
7498027 Methods of treatment using human tumor necrosis factor receptor TR17 antibodies
7501123 Human G-protein chemokine receptor (CCR5) HDGNR10
7504105 Treatment using antibodies to cytokine receptor common gamma chain like
7504481 TRP channel family member, LTRPC3 polypeptides
7507413 Albumin fusion proteins
7507414 Albumin fusion proteins
7511017 Methods of treatment with TNFR5
7514079 Antibodies that specifically bind to neurokinin B
7514099 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7598348 Adiponectin receptor variant, AdipoR2v2

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.